The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer

Honglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li · 2024

Read The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer by Honglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11618660.txt.

Description

Honglei Tao and co-authors report in 2024 that a pain drug mix may also fight lung cancer. Pain control is a core part of cancer care, but whether pain and numbing drugs help or harm tumors stays debated. The team screened sixteen common such drugs against non-small cell lung cancer cells.

One mix, butorphanol tartrate injection, stood out: it slowed cancer cell growth and made a drug-resistant cell line respond again to a standard targeted drug. Its main active part, benzethonium chloride, seems to act through a guard protein pathway that steers cell cycles and cell death. The find gives a base for pairing pain care with cancer care.

Catalog record

CREATORHonglei Tao, Lei Li, Huiling Li, Tingting Ma, Xinping Zhu, Jili Cao, Yongqiang Zhu, Shengmei Zhu, Mingqian Li
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11618660

Browse the full library · About the Tower of Babel